What's new

[PIO] European Prostate Cancer Day

30087.jpg





September 15th has been established as the European Day against Prostate Cancer, in order to inform and raise awareness among the male population of the Old Continent about the risks of prostate cancer and the possibility of treating it.

Prostate cancer is the most common cancer in men in Europe, and the second most common cancer in men worldwide. It is estimated that 1 in 7 men will develop prostate cancer in their lifetime.

The disease is considered to be relatively slow progressing, which is why it is particularly important to diagnose it in its early stages, when it is still only found in the prostate and is considered fully curable. When detected in the early stages, the percentage of patients who are fully cured is over 95% as there is now a plethora of treatment options available. However, when diagnosed in advanced stages, the rate drops to 20%. It is therefore very important to be diagnosed early, and men over the age of 50 should have their prostate screened every year.

Since the disease is usually asymptomatic, it can only be detected in early stages through regular clinical screening, which should start at the age of 50.

The main prostate examinations are a specific blood test measuring the prostate specific antigen PSA and a prostate finger test, in which the gland is palpated to see if there are any abnormalities in its size, shape and texture.

The combination of these two methods can give the most accurate information about the presence or absence of the disease. In cases of a family history of prostate cancer in first-degree relatives, the examination should start at the age of 45 years.

The choice of treatment is based on the degree of malignancy of the tumour, its size, the presence of metastases and age, as well as the general clinical condition of the patient.

Total removal of the prostate (radical prostatectomy) is the most common treatment for localised prostate cancer. It is usually performed between the ages of 50 and 70 years. Alternative treatment is radiation of the prostate (external brachytherapy) and in cases of metastatic prostate cancer, hormone therapy can inhibit further spread of the disease.

Early, regular screening is a simple procedure that protects men and saves lives!

(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO

Source

[/URL]

 
Back
Top